Efficacy and Safety of Gemlapodect (NOE-105) in Adults and Adolescents With Tourette Syndrome
Clinical trial NCT06315751 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06315751
- Sponsor
- Noema Pharma AG
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-10
- Primary completion
- 2026-06-01
- Enrollment
- 164
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.